When should we delay highly active antiretroviral therapy?
about
Hepatitis C virus infection in san francisco’s HIV-infected urban poorIllicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenClinical importance of HIV and depressive symptoms among veterans with HIV infection.Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug usePreventing HIV antiretroviral resistance through better monitoring of treatment adherence.Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease.Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women.
P2860
Q27473306-428E3117-7816-4BA5-AC80-AB56A302AB94Q33563439-3AA92FF7-3CFA-41CE-9878-C5705BBBBD28Q34743154-BC47102A-C8F1-41E6-B009-AB8BAB493D23Q34795087-47C9C534-680F-49B8-9F2B-2738682BF453Q36410265-86E83CB1-F8AE-4B7C-B17E-A2A9DBDD0146Q37068828-EDEAAE48-D446-4BBB-A122-39249E3DC3E5Q37151302-52E96787-F160-4099-B7F7-2FBC385238BFQ43752658-BE317F27-E0BC-40D0-9EAC-363A7C59FAB8Q46238724-3B2CE76D-6921-4D3C-B477-FF8F4AB0B0C6Q46843464-39CB7F2C-B70A-429E-9DC1-5AEA74B2EB9C
P2860
When should we delay highly active antiretroviral therapy?
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
When should we delay highly active antiretroviral therapy?
@en
When should we delay highly active antiretroviral therapy?
@nl
type
label
When should we delay highly active antiretroviral therapy?
@en
When should we delay highly active antiretroviral therapy?
@nl
prefLabel
When should we delay highly active antiretroviral therapy?
@en
When should we delay highly active antiretroviral therapy?
@nl
P2860
P1476
When should we delay highly active antiretroviral therapy?
@en
P2093
P2860
P304
P356
10.1046/J.1525-1497.1999.05109.X
P577
1999-07-01T00:00:00Z
P5875
P6179
1003422658